Resting and Dynamic Brain Glutamate by MRS In Vivo: Relation to Suicidal Behavior (Depressed Patients with a Recent Suicide Attempt)
A Neuroimaging Study on Brain Chemistry in Depression and Suicidal Behavior
Sponsor: National Institute of Mental Health
Enrolling: Male and Female Patients
Study Length: 1 Months
Clinic Visits: 3
IRB Number: AAAV4037
Contact: Camila Gomez Restrepo: 929-646-8598 / herzoglab@cumc.columbia.edu
Additional Study Information: HAVE YOU HAD A SUICIDE ATTEMPT WITHIN THE LAST 5 YEARS? We are conducting a study on depression and suicide risk, and participants can earn up to $300. Suicide rates in the U.S. are rising, and new treatments are urgently needed. This study focuses on glutamate, a brain chemical that may play an important role in mood and mental health. We will compare glutamate levels in people with depression with and without a history of suicide attempts and in healthy volunteers. We are looking for people with depression who have had a suicide attempt within the last 5 years. Please email herzoglab@cumc.columbia.edu for more information.
Investigator
Sarah Herzog, PhD
Do You Qualify?
Have you had ketamine in any form in the last 3 months? Yes No
Are you currently pregnant, breastfeeding, or trying to become pregnant? Yes No
Do you have a parent, child, or sibling with a history of schizophrenia? Yes No
Do you have conditions requiring daily use of stimulants, anxiety or sleep medications, antihistamines, or NSAIDs? Yes No
Have you had a suicide attempt within the last 5 years? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.


For more information, please contact:
Camila Gomez Restrepo
herzoglab@cumc.columbia.edu
929-646-8598